Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.
Clinical & translational immunology
View this publicationClinical & translational immunology
View this publicationBioinformatics (Oxford, England)
View this publicationAmerican journal of medical genetics. Part A
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationCommunications biology
View this publicationParasites & vectors
View this publicationEuropean journal of heart failure
View this publicationNature immunology
View this publicationClinical and translational science
View this publicationBritish journal of clinical pharmacology
View this publication